Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Weekly Wrap 21 February

Bell Direct
February 21, 2025

Morning Bell 20 February

Bell Direct
February 20, 2025

Morning Bell 19 February

Bell Direct
February 19, 2025

Morning Bell 18 February

Bell Direct
February 18, 2025

Morning Bell 17 February

Bell Direct
February 17, 2025

Weekly Wrap 14 February

Bell Direct
February 14, 2025

Morning Bell 13 February

Bell Direct
February 13, 2025

Morning Bell 12 February

Bell Direct
February 12, 2025

Morning Bell 11 February

Bell Direct
February 11, 2025